Neumora Therapeutics Inc. Common Stock
NMRA | NASDAQ
$0.75
+$0.06 (+8.41%)
Sep 22, 2026, 11:03 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -43.08M | -53.46M | -59.45M | -56.76M | -52.73M | -67.99M | -58.82M | -72.55M | -58.7M | -53.72M | -108.73M | -53.03M | -38.54M | -35.63M | -28.15M | -29.34M | -30.37M | -43.04M | -26.97M | -178.03M | -17.01M | -15.3M |
Depreciation & Amortization | 7K | 8K | 9K | 23K | 19K | 157K | 157K | 156K | 160K | 158K | 166K | 173K | 171K | 158K | 147K | 146K | 154K | 147K | 131K | 150K | 125K | 132K |
Stock-Based Compensation | 7.18M | 7.41M | 7.41M | 5.98M | 7.17M | 9.32M | 9.9M | 9.95M | 12.77M | 7.37M | 6.05M | 6.45M | 2.54M | 2.2M | 2.79M | 2.1M | 1.75M | 1.65M | 1.22M | 1.19M | 1.06M | 810K |
Other Working Capital | -31.06M | -2.44M | 379K | 4.58M | -7.2M | 1.73M | 1.54M | 24.41M | -8.62M | 2.44M | -11.2M | -1.5M | -1.94M | 6.32M | -2.07M | -47K | 456K | -4.04M | -3.61M | 2.49M | 1.87M | -949K |
Other Non-Cash Items | 28.33M | 406K | 870K | -364K | 747K | -412K | -225K | -472K | -1.35M | -356K | 64.18M | -177K | -290K | -78K | 18K | 778K | 157K | 13.11M | 750K | 157.18M | 73K | 42K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -31.97M | -765K | 3.21M | 4.48M | -7.6M | -525K | -1.36M | 29.43M | -9.03M | 3.59M | -13.11M | -1.19M | 5.1M | 309K | -5.18M | 555K | 1.73M | -4.06M | -4.48M | 2.25M | 2.19M | -924K |
Operating Cash Flow | -39.53M | -46.4M | -47.96M | -46.63M | -52.4M | -59.45M | -50.34M | -33.48M | -56.16M | -42.96M | -51.44M | -47.77M | -31.02M | -33.04M | -30.37M | -25.76M | -26.58M | -32.19M | -29.35M | -17.26M | -13.57M | -15.24M |
Capital Expenditures | n/a | n/a | 16K | -16K | n/a | n/a | n/a | n/a | n/a | n/a | -44K | -37K | n/a | -36K | -23K | -130K | -182K | -176K | -188K | -217K | -139K | -273K |
Cash Acquisitions | n/a | 71K | n/a | 87K | 84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -137K | n/a | -39.38M | -44.39M | -106.9M | 16K | -19.54M | -185.8M | -20.07M | -12.86M | -34.66M | -41.48M | -48.1M | -12.48M | -93.36M | -72.43M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 42.58M | 51.25M | 68.8M | 88.55M | 8.1M | 156.97M | 40.79M | 36.58M | 38.38M | 36.71M | 58.74M | 44.34M | 40.09M | 29.3M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 184K | n/a | 896K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.48M | -13M | n/a | -330K | 30K | 300K |
Investing Cash Flow | n/a | 71K | 42.65M | 51.32M | 30.4M | 44.16M | -98.8M | 156.99M | 21.26M | -150M | 13.68M | 23.82M | 24.08M | 2.82M | -8.03M | 16.69M | -91.07M | -85.61M | -188K | -547K | -109K | 27K |
Debt Repayment | n/a | n/a | 38.9M | -136K | 18.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -445K | n/a | 19.65M | n/a | n/a | n/a | 1.88M | -225K | n/a | n/a | n/a | 232.02M | 292K | 101K | 1.86M | 87.18M | 2.08M | -351K | -295K | 291.99M | 640K | 280K |
Financial Cash Flow | 9.29M | 10.88M | 58.77M | -136K | 18.46M | n/a | 15.57M | 1.53M | 2.65M | 1.85M | -481K | 232.02M | 292K | 101K | 26.83M | 87.18M | 2.08M | -351K | -358K | 291.99M | 640K | 1.24M |
Net Cash Flow | -30.24M | -35.46M | 53.46M | 4.55M | -3.55M | -15.29M | -133.57M | 125.04M | -32.25M | -191.11M | -38.25M | 208.07M | -6.65M | -30.12M | -11.56M | 78.11M | -115.57M | -118.14M | -29.9M | 274.18M | -13.04M | -13.98M |
Free Cash Flow | -39.53M | -46.4M | -47.94M | -46.65M | -52.4M | -59.45M | -50.34M | -33.48M | -56.16M | -42.96M | -51.49M | -47.81M | -31.02M | -33.08M | -30.39M | -25.89M | -26.76M | -32.36M | -29.54M | -17.47M | -13.71M | -15.52M |
Adj. Free Cash Flow | -46.71M | -53.81M | -55.35M | -52.63M | -59.57M | -68.77M | -60.24M | -43.43M | -68.93M | -50.33M | -57.54M | -54.26M | -33.57M | -35.27M | -33.18M | -28M | -28.51M | -34.02M | -30.76M | -18.67M | -14.76M | -16.33M |
Maintenance CapEx | n/a | n/a | -9K | -16K | n/a | n/a | n/a | n/a | n/a | n/a | -44K | -37K | n/a | -36K | -23K | -130K | -154K | -147K | -131K | -150K | -125K | -132K |
Growth CapEx | n/a | n/a | 25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28K | -29K | -57K | -67K | -14K | -141K |
Owner Earnings | -39.53M | -46.4M | -47.96M | -46.65M | -52.4M | -59.45M | -50.34M | -33.48M | -56.16M | -42.96M | -51.49M | -47.81M | -31.02M | -33.08M | -30.39M | -25.89M | -26.73M | -32.33M | -29.48M | -17.41M | -13.69M | -15.38M |
Add to Watchlist
Select watchlists to add or remove NMRA